KRAS and colonic neoplasm: By proteomic analysis, mutant KRAS colon cancer-derived EVs were discovered to transport mutant KRAS and other oncogenic proteins such as EGFR, SRC family kinases and integrins, toward neighbor cancer cells with wild-type KRAS, leading to enhanced growth of these neighbor cancer cells [135].